Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 178

The DOI matches its Crossref record.

The majority of CD1d‐sulfatide‐specific T cells in human blood use a semiinvariant Vδ1 TCR

Open access
Bai, Li, Picard, Damien, Anderson, Brian, Chaudhary, Vinod, Luoma, Adrienne, Jabri, Bana, Adams, Erin J., Savage, Paul B., Bendelac, Albert · 2012 · European Journal of Immunology

Abstract

αβ T‐cell lines specific for sulfatide, an abundant myelin glycosphingolipid presented by various CD1 molecules, have been previously derived from PBMCs of patients with demyelinating diseases such as multiple sclerosis (MS) but also from healthy subjects. Using an unbiased tetramer‐based MACS enrichment method to enrich for rare antigen‐specific cells, we confirmed the presence of CD1d‐sulfatide‐specific T cells in all healthy individuals examined. Surprisingly, the great majority of fresh sulfatide‐specific T cells belonged to the γδ lineage. Furthermore, these cells used the Vδ1 TCR variable segment, which is uncommon in the blood but predominates in tissues such as the gut and specifically accumulates in MS lesions. Recombinant Vδ1 TCRs from different individuals were shown to bind recombinant CD1d‐sulfatide complexes in a sulfatide‐specific manner. These results provide the first direct demonstration of MHC‐like‐restricted, antigen‐specific recognition by γδ TCRs. Together with previous reports, they support the notion that human Vδ1 T cells are enriched in CD1‐specific T cells and suggest that the Vδ1 T‐cell population that accumulates in MS lesions might be enriched in CD1‐sulfatide‐specific cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201242531

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Bai, L., Picard, D., Anderson, B., Chaudhary, V., Luoma, A., Jabri, B., Adams, E. J., Savage, P. B., & Bendelac, A.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2012-07-25
Volume
42
Issue
9
Pages
2505-2510
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W1505219365
Cited by
178
References
0
FWCI
5.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.